Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies
Open Access
- 27 January 2022
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (3) , 1441
Abstract
Omics studies are crucial to improve our understanding of myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults. Employing tissue samples and cell lines derived from patients and animal models, omics approaches have revealed the myriad alterations in gene and microRNA expression, alternative splicing, 3′ polyadenylation, CpG methylation, and proteins levels, among others, that contribute to this complex multisystem disease. In addition, omics characterization of drug candidate treatment experiments provides crucial insight into the degree of therapeutic rescue and off-target effects that can be achieved. Finally, several innovative technologies such as single-cell sequencing and artificial intelligence will have a significant impact on future DM1 research.Keywords
Funding Information
- Generalitat Valenciana (Grisoliap2018/098, PROMETEO/2020/081)
- 'la Caixa' Foundation (HR17-00268)
This publication has 98 references indexed in Scilit:
- Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 LocusPLOS Genetics, 2012
- Ending the message: poly(A) signals then and nowGenes & Development, 2011
- The importance of CELF control: molecular and biological roles of the CUG‐BP, Elav‐like family of RNA‐binding proteinsWIREs RNA, 2011
- A critical role for TCF-1 in T-lineage specification and differentiationNature, 2011
- RNA-binding Protein Muscleblind-like 3 (MBNL3) Disrupts Myocyte Enhancer Factor 2 (Mef2) β-Exon SplicingJournal of Biological Chemistry, 2010
- Expansion of CUG RNA repeats causes stress and inhibition of translation in myotonic dystrophy 1 (DM1) cellsThe FASEB Journal, 2010
- Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophyNature Structural & Molecular Biology, 2010
- Pentamidine reverses the splicing defects associated with myotonic dystrophyProceedings of the National Academy of Sciences, 2009
- A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heartProceedings of the National Academy of Sciences, 2008
- CTG Trinucleotide Repeat “Big Jumps”: Large Expansions, Small MicePLOS Genetics, 2007